Delivery Order SPE2DB22D3501-SPE2DB24FWX71
- Not listed
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $9,010.50 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to provide the pharmaceutical product TRODELVY 180 MG VIALS. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,010.50 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product TRODELVY 180MG VIAL 1S, with a period of performance through May 9, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $9,010.50 firm-fixed-price delivery order is for the supply of 4,565,814,840 units of the oncology drug Trodelvy (180mg vial). The contract has a completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $12,014 for the supply of TRODELVY 180 MG VIALS. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This is a firm-fixed-price delivery order awarded by the Medical Supply Chain, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp's Corporate Office Division. The $15,017.50 contract is for the supply of Trodelvy 180 mg vials, a specialty oncology medication. The order has a performance period through May 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract with the Defense Logistics Agency...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $10,512.25 firm-fixed-price delivery order is for the supply of TRODELVY 180 MG VIALS, a specialty oncology medication. The contract has an ultimate completion date of October 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,584.58 firm fixed-price delivery order is for the supply of TRODELVY 180MG VIAL 1S medical products, with a completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $36,042 for the supply of Trodelvy 180 mg vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,974.30 firm fixed-price contract provides for the delivery of 180 mg vials of the drug TRODELVY. The contract has an ultimate completion date of April 2, 2025 and was awarded on March 12, 2025. This order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the supply of TRODELVY 180 MG VIALS, a pharmaceutical product, with a ceiling value of $12,779.44 and a completion date of August 7, 2025. The contract is a firm fixed-price delivery order, and it is not a set-aside contract. AmerisourceBergen Drug Corp has an Indefinite Delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FWX71Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $9,010.50 firm fixed-price contract is for the supply of 180 mg vials of the oncology medication Trodelvy. The order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs. The award does not utilize a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to deliver critical medications and medical commodities to federal agencies and healthcare facilities across the United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 9/11/24 |